About CLS
News and insights
©Copyright 2024 CLS AB. All rights reserved.
MM-2022-025/Rev2
Here you can find the regulatory notices published in accordance with the listing requirements of Nasdaq First North Stockholm where CLS’ shares are listed, and other applicable rules and regulations.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region
©Copyright 2024 CLS AB. All rights reserved.
MM-2022-025/Rev2